Published in Appl Opt on October 01, 1997
Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy. Lasers Med Sci (2004) 1.39
Transient absorption changes in vivo during photodynamic therapy with pulsed-laser light. Br J Cancer (1999) 0.85
Determining the optical properties of a gelatin‑TiO(2) phantom at 780 nm. Biomed Opt Express (2012) 0.78
Necrosis response to photodynamic therapy using light pulses in the femtosecond regime. Lasers Med Sci (2012) 0.77
Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy. Theranostics (2016) 0.77
Towards PDT with Genetically Encoded Photosensitizer KillerRed: A Comparison of Continuous and Pulsed Laser Regimens in an Animal Tumor Model. PLoS One (2015) 0.76
Empirical Modeling of Physiochemical Immune Response of Multilayer Zinc Oxide Nanomaterials under UV Exposure to Melanoma and Foreskin Fibroblasts. Sci Rep (2017) 0.75
Application of lower fluence rate for less microvasculature damage and greater cell-killing during photodynamic therapy. Lasers Med Sci (2005) 0.75
Photodynamic effects of zinc oxide nanowires in skin cancer and fibroblast. Lasers Med Sci (2013) 0.75
A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo. Med Phys (1992) 5.15
Time resolved reflectance and transmittance for the non-invasive measurement of tissue optical properties. Appl Opt (1989) 4.42
Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers Surg Med (1992) 3.34
In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem Photobiol (1998) 3.18
Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys (2005) 3.17
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. J Clin Immunol (1981) 2.92
Implicit and explicit dosimetry in photodynamic therapy: a New paradigm. Lasers Med Sci (1997) 2.52
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes. Heart (2008) 2.40
Improved solutions of the steady-state and the time-resolved diffusion equations for reflectance from a semi-infinite turbid medium. J Opt Soc Am A Opt Image Sci Vis (1997) 2.18
Monte Carlo modeling of light propagation in highly scattering tissue--I: Model predictions and comparison with diffusion theory. IEEE Trans Biomed Eng (1989) 2.08
Spatially resolved absolute diffuse reflectance measurements for noninvasive determination of the optical scattering and absorption coefficients of biological tissue. Appl Opt (1996) 2.05
A Monte Carlo model for the absorption and flux distributions of light in tissue. Med Phys (1984) 1.87
Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol (2009) 1.84
Three-dimensional miniature endoscopy. Nature (2006) 1.82
Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol (2001) 1.82
Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79
Determination of the optical properties of turbid media from a single Monte Carlo simulation. Phys Med Biol (1996) 1.73
Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Methods Enzymol (1983) 1.72
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
Fiber-optic bundle design for quantitative fluorescence measurement from tissue. Appl Opt (1998) 1.61
Imaging of fluorescent yield and lifetime from multiply scattered light reemitted from random media. Appl Opt (1997) 1.53
Microwave image reconstruction utilizing log-magnitude and unwrapped phase to improve high-contrast object recovery. IEEE Trans Med Imaging (2001) 1.51
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer (2009) 1.51
Noninvasive determination of the optical properties of two-layered turbid media. Appl Opt (1998) 1.49
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest Endosc (2001) 1.48
Spectroscopic diffuse optical tomography for the quantitative assessment of hemoglobin concentration and oxygen saturation in breast tissue. Appl Opt (1999) 1.45
Lessons learned from laser tissue soldering and fibrin glue pyeloplasty in an in vivo porcine model. J Urol (2000) 1.44
The use of India ink as an optical absorber in tissue-simulating phantoms. Phys Med Biol (1992) 1.44
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer (1994) 1.43
Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA). Photochem Photobiol (1994) 1.42
Optical properties of normal and diseased human breast tissues in the visible and near infrared. Phys Med Biol (1990) 1.40
High-resolution near-infrared tomographic imaging simulations of the rat cranium by use of a priori magnetic resonance imaging structural information. Opt Lett (1998) 1.39
Antibody-targeted photolysis: selective photodestruction of human T-cell leukemia cells using monoclonal antibody-chlorin e6 conjugates. Proc Natl Acad Sci U S A (1986) 1.36
Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy. Radiat Res (1997) 1.35
Kinetic studies of a quantitative single-tube enzyme-linked immunosorbent assay. Clin Chem (1980) 1.33
Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid. Br J Cancer (2005) 1.32
Mathematical model for time-resolved and frequency-domain fluorescence spectroscopy in biological tissues. Appl Opt (1994) 1.32
Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology (1994) 1.27
Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology (1996) 1.25
Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol (1995) 1.24
Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett (2002) 1.23
Photodynamic synovectomy using benzoporphyrin derivative in an antigen-induced arthritis model for rheumatoid arthritis. Photochem Photobiol (1998) 1.21
Noninvasive measurement of fluorophore concentration in turbid media with a simple fluorescence /reflectance ratio technique. Appl Opt (2001) 1.20
Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18
Quantification of bioluminescence images of point source objects using diffusion theory models. Phys Med Biol (2006) 1.17
Schistosoma mansoni adult microsomal antigens, a serologic reagent. I. Systematic fractionation, quantitation, and characterization of antigenic components. J Immunol (1983) 1.17
Effect of charge on the interaction of site-specific photoimmunoconjugates with human ovarian cancer cells. Cancer Res (1996) 1.17
Frequency-domain optical absorption spectroscopy of finite tissue volumes using diffusion theory. Phys Med Biol (1994) 1.17
In vivo near-infrared Raman spectroscopy: demonstration of feasibility during clinical gastrointestinal endoscopy. Photochem Photobiol (2000) 1.16
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer (2006) 1.16
Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res (2001) 1.15
Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther (2000) 1.14
Photodynamic treatment of rheumatoid and inflammatory arthritis. Photochem Photobiol (1996) 1.13
A solubilization technique for photosensitizer quantification in ex vivo tissue samples. J Photochem Photobiol B (1997) 1.13
Photoimmunotherapy of human ovarian carcinoma cells ex vivo. Cancer Res (1991) 1.12
In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol (1990) 1.12
Comparison of narrowband ultraviolet B exposure and oral vitamin D substitution on serum 25-hydroxyvitamin D concentration. Br J Dermatol (2012) 1.12
Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. Br J Cancer (1998) 1.12
Monte Carlo modeling of light propagation in highly scattering tissues--II: Comparison with measurements in phantoms. IEEE Trans Biomed Eng (1989) 1.12
In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med (2007) 1.11
Optical and thermal characterization of natural (Sepia officinalis) melanin. Photochem Photobiol (1994) 1.11
Effects of femtosecond laser irradiation on osseous tissues. Lasers Surg Med (2007) 1.11
Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res (1998) 1.11
Influence of layered tissue architecture on estimates of tissue optical properties obtained from spatially resolved diffuse reflectometry. Appl Opt (1998) 1.10
Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res (1997) 1.10
Experimental tests of the feasibility of singlet oxygen luminescence monitoring in vivo during photodynamic therapy. J Photochem Photobiol B (1990) 1.09
Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08
The physics of photodynamic therapy. Phys Med Biol (1986) 1.08
Photoluminescence spectroscopy of carbon nanotube bundles: evidence for exciton energy transfer. Phys Rev Lett (2007) 1.07
Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience (2000) 1.07
BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cells. Br J Cancer (1999) 1.07
Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library. J Immunol Methods (2001) 1.06
Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06
The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol (1997) 1.06
Anisotropy of light propagation in human skin. Phys Med Biol (2000) 1.06
Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitis. Br J Dermatol (2010) 1.06
The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol (1996) 1.06
Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology (1994) 1.06
Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice. Int J Cancer (1996) 1.05
Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake. Cancer Res (1993) 1.04
Ultrasound properties of liver tissue during heating. Ultrasound Med Biol (1997) 1.04
Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol (1996) 1.03
Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J Urol (1995) 1.03